Compare UBER & BME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | UBER | BME |
|---|---|---|
| Founded | 2009 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Trusts Except Educational Religious and Charitable |
| Sector | Consumer Discretionary | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 195.5B | 536.7M |
| IPO Year | 2019 | N/A |
| Metric | UBER | BME |
|---|---|---|
| Price | $81.19 | $41.28 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 35 | 0 |
| Target Price | ★ $108.75 | N/A |
| AVG Volume (30 Days) | ★ 20.1M | 34.0K |
| Earning Date | 02-04-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 6.26% |
| EPS Growth | ★ 286.11 | N/A |
| EPS | ★ 7.80 | 1.44 |
| Revenue | ★ $49,610,000,000.00 | N/A |
| Revenue This Year | $20.62 | N/A |
| Revenue Next Year | $15.86 | N/A |
| P/E Ratio | ★ $10.41 | $28.37 |
| Revenue Growth | ★ 18.25 | N/A |
| 52 Week Low | $60.02 | $35.53 |
| 52 Week High | $101.99 | $43.20 |
| Indicator | UBER | BME |
|---|---|---|
| Relative Strength Index (RSI) | 38.24 | 63.56 |
| Support Level | $80.35 | $40.41 |
| Resistance Level | $82.25 | $41.12 |
| Average True Range (ATR) | 2.19 | 0.42 |
| MACD | -0.26 | 0.00 |
| Stochastic Oscillator | 19.63 | 100.00 |
Uber Technologies is a technology provider that matches riders with drivers, hungry people with restaurants and food couriers, and shippers with carriers. The firm's on-demand technology platform is currently utilized by traditional cars as well as autonomous vehicles, but could eventually be used for additional products and services, such as delivery via drones or electronic vehicle take-off and landing (eVTOL) technology. Uber operates in over 70 countries, with over 180 million users who order rides or food at least once a month.
Blackrock Health Sciences Trust has an investment objective to provide total return through a combination of current income, current gains, and long-term capital appreciation. The Fund invests 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives.